struggling-company-faces-downward-spiral-amid-negative-metrics
Legacy AI Deep Dive Analysis of OCEAN BIOMEDICAL INC (OCEA)
Sorry, there seems to be a mix-up. Could you please provide financial-related information so I can assist you accordingly?
As of June 30, 2024, Ocean Biomedical, Inc. has 34,868,628 shares issued and outstanding, up from 34,649,046 shares as of December 31, 2023. Its additional paid-in capital has increased to 107,547 from 105,292, while its accumulated deficit has grown from 196,055 to 200,290. This results in a total stockholders deficit of 92,743, compared to 90,763 previously. Total liabilities and stockholders deficit amount to 1,851, down from 5,501.
For the six months ended June 30, 2024, the company's research and development expenses were 26, compared to 421 in the same period in 2023. General and administrative expenses fell from 7,798 to 1,251. Total operating expenses were 1,277, down from 8,219 the previous year.
1) Brief Summary:
The provided metrics indicate a severely underperforming company. The negative Simple Moving Averages (SMA50, SMA200, and SMA20) suggest a strong downward trend. The company has shown a significant decrease in performance over the past week, month, and quarter. Additionally, the company's Return on Equity (ROE) is worryingly negative, and there is a substantial amount of short interest in the stock, further adding to the bearish sentiment. The company's financials also indicate a concerning situation with negative revenues, high liabilities, and negative equity. Moreover, the company has a small number of employees and has not reported any sales growth over the past 5 years.
2) MARKET_SCORE:
Given the negative performance indicators and financial metrics, I would estimate a low likelihood of an upward move. MARKET_SCORE: 10
3) PRICE_TARGET: With the current price at $0.0568 and considering the negative trends and financials, it's challenging to anticipate a higher price target. However, to give a somewhat optimistic estimate, let's say the price could potentially increase by 10%. Thus, PRICE_TARGET: $0.0625
4) AI_RPT_HEADLINE: "Struggling Company Faces Downward Spiral Amid Negative Metrics"
3) PRICE_TARGET: With the current price at $0.0568 and considering the negative trends and financials, it's challenging to anticipate a higher price target. However, to give a somewhat optimistic estimate, let's say the price could potentially increase by 10%. Thus, PRICE_TARGET: $0.0625
4) AI_RPT_HEADLINE: "Struggling Company Faces Downward Spiral Amid Negative Metrics"
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
======================================================
: 2025-03-26 02:45:48
# Analysis Completed Elapsed Time: 40.68 seconds
# Analysis Completed Elapsed Time: 40.68 seconds
Welcome to ScanScor. What you're reading is one of our system legacy reports and the result of a carefully-crafted interactive session with OpenAI's most advanced models . This report is one of our early attempts to maximize the potential for OpenAI's smartest GPT-based analysis engine, guided by tightly structured prompts to expose the forces behind today's market movers.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment. This particular report predates the BPE and is here for historic value.